Virus immunization using entity-sponsored bypass network

• US 20070256131A1
• Filed: 11/16/2006
• Published: 11/01/2007
• Est. Priority Date: 04/27/2006
• Status: Active Grant

• Current Assignee: The Invention Science Fund I, L.L.C. (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC), State of Delaware
• Inventors: Lord, Robert W., Jung, Edward K.Y., Levien, Royce A., Malamud, Mark A., Rinaldo, John D., Wood, Lowell L.
• Granted Patent: US 7,849,508 B2
• Time in Patent Office: Days
• US Class Current: 726/24
• CPC Class Codes: H04L 63/1441 Countermeasures against malicious traffic countermeasures against attacks on cryptographic mechanisms H04L9/002
• CPC Class Codes: H04L 63/18 using different networks or channels, e.g. using out of band channels cryptographic mechanisms or cryptographic arrangements for key distribution involving distinctive intermediate devices or communication paths H04L9/0827; cryptographic mechanisms or cryptographic arrangements for authentication using a plurality of channels H04L9/3215

Abstract

An apparatus, device, method, computer program product, and system are described that in some instances may provide access to at least one bypass network, provide distribution of an anti-viral agent onto a communications network associated with a virus, using the at least one bypass network, and provide an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to the providing the distribution

Claims

1. A system comprising:

circuitry for providing access to at least one bypass network;

circuitry for providing distribution of an anti-viral agent onto a communications network associated with a virus, using the at least one bypass network; and

circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution.

3. The system of claim 1 wherein circuitry for providing access to at least one bypass network comprises:

circuitry for providing access to the at least one bypass network, based on a service level agreement with a distributing entity of the anti-viral agent to whom the access is provided.

5. The system of claim 1 wherein circuitry for providing access to at least one bypass network comprises:

circuitry for providing fee-based access to the at least one bypass network.

6. The system of claim 1 wherein circuitry for providing access to at least one bypass network comprises:

circuitry for providing access to the at least one bypass network for an anti-viral service provider.

8. The system of claim 1 wherein circuitry for providing access to at least one bypass network comprises:

circuitry for providing access to the at least one bypass network to a network service provider.

10. The system of claim 1 wherein circuitry for providing access to at least one bypass network comprises:

circuitry for providing access to the at least one bypass network, the at least one bypass network including a physically-separate network from the communications network.

12. The system of claim 1 wherein circuitry for providing access to at least one bypass network comprises:

circuitry for providing access to the at least one bypass network, the at least one bypass network including at least two bypass networks having entity-sponsored assurance of transmission therebetween.

13. The system of claim 1 wherein circuitry for providing access to at least one bypass network comprises:

circuitry for providing access to an immunization system in communications with the at least one bypass network.

18. The system of claim 1 wherein circuitry for providing distribution of an anti-viral agent onto a communications network associated with a virus, using the at least one bypass network, comprises:

circuitry for allowing a distributing entity of the anti-viral agent to manage resources of the at least one bypass network.

20. The system of claim 1 wherein circuitry for providing distribution of an anti-viral agent onto a communications network associated with a virus, using the at least one bypass network, comprises:

circuitry for distributing the anti-viral agent based on a request from a distributing entity of the anti-viral agent.

21. The system of claim 1 wherein circuitry for providing distribution of an anti-viral agent onto a communications network associated with a virus, using the at least one bypass network, comprises:

circuitry for providing distribution of an anti-viral agent onto a communications network associated with the virus, the virus being transmitted on the communications network.

23. The system of claim 1 wherein circuitry for providing distribution of an anti-viral agent onto a communications network associated with a virus, using the at least one bypass network, comprises:

circuitry for providing distribution of a reference to the anti-viral agent to a network device of the communications network, wherein the reference provides access to the anti-viral agent.

26. The system of claim 1 wherein circuitry for providing distribution of an anti-viral agent onto a communications network associated with a virus, using the at least one bypass network, comprises:

circuitry for providing prioritized routing of the anti-viral agent, relative to communications data of the communications network.

30. The system of claim 1 wherein circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution comprises:

circuitry for providing the entity-sponsored assurance of the transmission characteristic, the transmission characteristic including a lower transmission latency of the anti-viral agent on the at least one bypass network relative to transmission of the virus on the communications network.

31. The system of claim 1 wherein circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution comprises:

circuitry for providing the entity-sponsored assurance of the transmission characteristic, the transmission characteristic including a higher transmission speed of the anti-viral agent on the at least one bypass network relative to transmission of the virus on the communications network.

32. The system of claim 1 wherein circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution comprises:

circuitry for providing the entity-sponsored assurance of the transmission characteristic, the transmission characteristic including a higher quality of service of transmission of the anti-viral agent on the at least one bypass network relative to transmission of the virus on the communications network.

33. The system of claim 1 wherein circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution comprises:

circuitry for providing the entity-sponsored assurance of the transmission characteristic, the transmission characteristic including a higher security transmission of the anti-viral agent on the at least one bypass network relative to transmission of the virus on the communications network.

34. The system of claim 1 wherein circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution comprises:

circuitry for providing the entity-sponsored assurance of the transmission characteristic, the transmission characteristic including a higher transmission reliability of the anti-viral agent on the at least one bypass network relative to transmission of the virus on the communications network.

35. The system of claim 1 wherein circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution comprises:

circuitry for providing the entity-sponsored assurance of the transmission characteristic, the transmission characteristic including a faster point-to-point delivery time of the anti-viral agent on the at least one bypass network relative to transmission of the virus on the communications network.

36. The system of claim 1 wherein circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution comprises:

circuitry for providing the entity-sponsored assurance of the transmission characteristic, the transmission characteristic including a faster end-to-end delivery time of the anti-viral agent on the at least one bypass network relative to transmission of the virus on the communications network.

37. The system of claim 1 wherein circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution comprises:

circuitry for entering an agreement with a distributing entity of the anti-viral agent.

38. The system of claim 1 wherein circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution comprises:

circuitry for providing a guarantee of the transmission characteristic to a distributing entity of the anti-viral agent.

39. The system of claim 1 wherein circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution comprises:

circuitry for providing a consequence of a failure to sufficiently provide the transmission characteristic during the distribution of the anti-viral agent.

40. The system of claim 1 wherein circuitry for providing an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution comprises:

circuitry for providing an assurance of a result of the distribution of the anti-viral agent.

2. (canceled)

4. (canceled)

7. (canceled)

9. (canceled)

11. (canceled)

14. (canceled)

15. (canceled)

16. (canceled)

17. (canceled)

19. (canceled)

22. (canceled)

24. (canceled)

25. (canceled)

27. (canceled)

28. (canceled)

29. (canceled)

41. (canceled)

42. (canceled)

43. (canceled)

44. (canceled)

45. (canceled)

46. (canceled)

47. (canceled)

48. (canceled)

49. (canceled)

50. (canceled)

51. (canceled)

52. (canceled)

53. (canceled)

54. (canceled)

55. (canceled)

56. (canceled)

57. (canceled)

58. (canceled)

59. (canceled)

60. (canceled)

61. (canceled)

62. (canceled)

63. (canceled)

64. (canceled)

65. (canceled)

66. (canceled)

67. (canceled)

68. (canceled)

69. (canceled)

70. (canceled)

71. (canceled)

72. (canceled)

73. (canceled)

74. (canceled)

75. (canceled)

76. (canceled)

77. (canceled)

78. (canceled)

79. (canceled)

80. (canceled)

81. (canceled)

82. (canceled)

83. (canceled)

84. (canceled)

85. (canceled)

86. (canceled)

87. A device comprising:

an entity-sponsored virus immunization system, the entity-sponsored virus immunization system including;

(a) access logic operable to provide access to at least one bypass network; and

(b) distribution logic operable to provide distribution of an anti-viral agent onto a communications network associated with a virus, using the at least one bypass network, and further operable to provide an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to the providing the distribution.

91. The device of claim 87 wherein the distribution logic is operable to provide the entity-sponsored assurance in accordance with an agreement with a distributing entity of the anti-viral agent.

88. (canceled)

89. (canceled)

90. (canceled)

92. A system comprising:

a computing device; and

instructions that when executed on the computing device cause the computing device to

(a) provide access to at least one bypass network,

(b) provide distribution of an anti-viral agent onto a communications network associated with a virus, using the at least one bypass network, and

(c) provide an entity-sponsored assurance of a transmission characteristic of the at least one bypass network with respect to a provision of the distribution.